Onyx Therapeutics, Inc. v. Cipla Ltd.
Case Name: Onyx Therapeutics, Inc. v. Cipla Ltd., No. 16-988-LPS, 2020 WL 2214443 (D. Del. May 4, 2020) (Stark, J.) Drug Product and Patent(s)-in-Suit: Kyprolis® (carfilzomib); U.S. Patents Nos....
View ArticleEagle Pharms. Inc. v. Slayback Pharma LLC
Case Name: Eagle Pharms. Inc. v. Slayback Pharma LLC, 958 F.3d 1171 (Fed. Cir. May 8, 2020) (Circuit Judges O’Malley, Reyna, and Chen presiding; Opinion by Reyna, J.) (Appeal from D. Del., Connolly,...
View ArticleBiogen Int’l GmbH v. Mylan Pharms. Inc.
Case Name: Biogen Int’l GmbH v. Mylan Pharms. Inc., No. 1:17-cv-116, 2020 WL 3317105 (N.D.W.V. June 18, 2020) (Keeley, J.) Drug Product and Patent(s)-in-Suit: Tecfidera® (dimethyl fumarate); U.S....
View ArticleFerring Pharms. Inc. v. Lupin Inc.
Case Name: Ferring Pharms. Inc. v. Lupin Inc., No. 19-913-RGA, 2020 WL 3414750 (D. Del. June 22, 2020) (Andrews, J.) Drug Product and Patent(s)-in-Suit: Clenpiq® (sodium picosulfate / magnesium oxide /...
View ArticleAdapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc.
Case Name: Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc., No. No. 16-7721 (BRM) (JAD), 2020 WL 3428078 (D.N.J. June 22, 2020) (Martinotti, J.) Drug Product and Patent(s)-in-Suit: Narcan®...
View ArticleH. Lundbeck A/S v. Apotex Inc.
Case Name: H. Lundbeck A/S v. Apotex Inc., No. 18-88-LPS, 2020 WL 3507795 (D. Del. June 26, 2020) (Stark, J.) Drug Product and Patent(s)-in-Suit: Trintellix® (vortioxetine); U.S. Patents Nos. 8,722,684...
View ArticleNew ANDA Cases
This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act. It also includes the same...
View ArticleGeneric Launches 505(b)(2)
This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications....
View ArticleANDA Litigation Settlements
This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases that are filed pursuant to the Hatch-Waxman Act....
View ArticleANDA Approvals
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA. table.tableizer-table {...
View ArticleFacing Novel Legal Issues Concerning Facial Recognition Technology in 2020
“Beware the Kodak,” warned TheHartfordDaily Courant in July 1888. “The sedate citizen can’t indulge in any hilariousness without incurring the risk of being caught in the act and having his photograph...
View ArticleInterview with Uzma Saghir, Senior Corporate Counsel at Liberty Mutual
Tell me about your current role.I work on the corporate side, for two main clients – Procurement and Meeting Management and Event Strategy. For Procurement, Liberty spends over $12 billion a year with...
View ArticleDon’t Stop the Music: The Intersection Between Insurance and The Music...
Several industries have been severely hit by the COVID-19 pandemic, and the music industry is certainly no exception. Although many artists have found creative ways to monetize their craft, such as...
View ArticleConservation Easement Deductions: How Recent Tax Law Developments Have...
I. Introduction A recent development in tax law has created a new, fertile area for recovery of losses via legal malpractice litigation. For years, tax attorneys recommended conservation easements to...
View ArticleTakeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc.
Case Name: Takeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc., No. 2020-1407, -1417 (Fed. Cir. July 31, 2020) (Circuit Judges Prost, Newman, and Hughes presiding; Opinion by Prost, C.J.; Dissent by...
View ArticleIBSA Institut Biochimique, S.A. v. Teva Pharms. USA, Inc.
Case Name: IBSA Institut Biochimique, S.A. v. Teva Pharms. USA, Inc., No. 2019-2400 (Fed. Cir. July 31, 2020) (Circuit Judges Prost, Reyna, and Hughes presiding; Opinion by Prost, C.J.) (Appeal from D....
View ArticleBristol-Myers Squibb Co. v. Aurobindo Pharma USA Inc.
Case Name: Bristol-Myers Squibb Co. v. Aurobindo Pharma USA Inc., No. 17-374-LPS (Consolidated), 2020 WL 4500226 (D. Del. Aug. 5, 2020) (Stark, J.) Drug Product and Patent(s)-in-Suit: Eliquis®...
View ArticleSun Pharm. Indus. Ltd. v. Saptalis Pharms., LLC
Case Name: Sun Pharm. Indus. Ltd. v. Saptalis Pharms., LLC, No. 18-648-WCB, 2020 WL 5077412 (D. Del. Aug. 6, 2020) (Bryson, J.) Drug Product and Patent(s)-in-Suit: Riomet® (metformin HCl); U.S. Patent...
View ArticleNovartis Pharms. Corp. v. Accord Healthcare Inc.
Case Name: Novartis Pharms. Corp. v. Accord Healthcare Inc., No. 18-1043-KAJ (D. Del. August 10, 2020) (Jordan, J.) Drug Product and Patent(s)-in-Suit: Gilenya® (fingolimod); U.S. Patent No. 9,187,405...
View ArticleNoven Pharm., Inc. v. Amneal Pharms. LLC
Case Name: Noven Pharm., Inc. v. Amneal Pharms. LLC, No. 18-cv-00699 (D. Del. Sept. 2, 2020) (Stark, J.) Drug Product and Patent(s)-in-Suit: Minivelle® (estradiol); U.S. Patents Nos. 9,833,419 (“the...
View Article